𝔖 Bobbio Scriptorium
✦   LIBER   ✦

557 POSTER Pre-clinical activity of the PARP inhibitor AZD2281 in homologous recombination repair deficient triple negative breast cancer

✍ Scribed by M.J. O'Connor; A. Lau; R.S. Finn; C. Knights; A. O'Shaughnessy; O. Kalous; D. Conklin; L. Riches; J. Carmichael; D.J. Slamon


Book ID
119599713
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
72 KB
Volume
6
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.